<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=510762&amp;fmt=gif">
Skip to content
Grace BaekJuly 23, 2025< 1 min read

Case Study - Teva

Case Study: Teva Pharmaceuticals 

Company: Teva Pharmaceuticals
Customer Overview

Teva Pharmaceuticals is a global leader in generic and specialty medicines. VROC initium helps the R&D site, where the team focuses on formulating stable, efficacious drug products across various dosage forms.

Key Challenges Addressed

  • Viscosity Optimization: Required precise control over viscosity for injectable and topical formulations to ensure bioavailability, ease of administration, and manufacturability.
  • Sample Volume Constraints: Faced limitations in early-phase formulation work where sample availability was minimal.
  • Automation & Efficiency: Sought ways to reduce manual effort in testing and improve throughput without compromising data quality.

Solutions Implemented

  • Instrument: VROC initium one
  • Application: Used to measure shear-dependent viscosity profiles of various formulations and injectables. Allowed for small-sample, high-accuracy testing.
  • Integration: Adopted into Teva’s formulation workflows for buffer, concentration and excipient screening.

Customer Success Highlights

  • Small sample volumes: For early stage formulation and lack of sample volume available overall.
  • Faster Development Cycles: Enabled more rapid decision-making during excipient selection and prototype evaluation.
  • Team Adoption: Tool is now a go-to for formulation screening across multiple projects.

 

COMMENTS